-
Mashup Score: 0Neighborhood Socioeconomic Status and Racial and Ethnic Survival Disparities in Oral Cavity and Laryngeal Cancer - 1 year(s) ago
AbstractBackground:. Oral cavity cancer (OCC) and laryngeal cancer are among the most common cancers worldwide. This study investigated survival in non-Hispanic (NH) Black, NH White, Asian, and Hispanic patients with OCC and laryngeal cancer of low, intermediate, and high neighborhood socioeconomic status (nSES).Methods:. We used data from the SEER 18 Census Tract-level SES and Rurality Database…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3AACR Annual Meeting 2022 — 2022 - 1 year(s) ago
The AACR Annual Meeting is the touchstone event for thought leaders from across the spectrum of cancer research, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to set the research agenda for the cancer community. After two years of virtual meetings, the AACR—through the leadership of 2021-2022 AACR President David A. Tuveson,…
Source: annualreport2022.aacr.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Transforming Patient Outcomes: #AACR22 showcased practice-changing trials, including the first to show a significant survival benefit for NSCLC patients from neoadjuvant immunotherapy combined with chemotherapy. Learn more in the AACR Annual Impact Report: https://t.co/TSJOq2wrV9 https://t.co/TjKAPrUKxu
-
-
Mashup Score: 0Black vs White Women With Breast Cancer Experience Varying Results With Neoadjuvant Endocrine Therapy - 1 year(s) ago
Nearly all patients with HR-positive breast cancer are treated with endocrine therapy, yet Black women are 4 times more likely to die of this disease compared with White women.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Nearly all patients with HR-positive breast cancer are treated with endocrine therapy, yet Black women are 4 times more likely to die of this disease compared with White women. #bcsm #AACR22 | @AACR @cityofhope https://t.co/rqGRivMfsc
-
-
Mashup Score: 1
Identifying a number of cancer predisposition genes could help improve upon risk assessment and counseling for ductal carcinoma in situ and contralateral breast cancer.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Pathogenic gene variants in a number of cancer predisposition genes have been identified as carrying a moderate or high risk of developing ductal carcinoma in situ or invasive ductal breast cancer for women. #bcsm #AACR22 | @MayoClinic https://t.co/5F8wsQRNxX https://t.co/AmSxTbRgby
-
-
Mashup Score: 0
Researchers have identified genetic variants in prostate tumors of men of African descent that appear to be associated with African ancestry. The findings of two studies — presented during American Association for Cancer Research Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved — demonstrated the potential impact of
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Genetic variants linked to aggressive prostate cancer in men of African ancestry. https://t.co/eSQ8qLvznv @AACR #AACR22 #aggressiveprostatecancer #prostatecancer #racialdisparity #OncAlert #HemOnc #Oncology
-
-
Mashup Score: 0Black vs White Women With Breast Cancer Experience Varying Results With Neoadjuvant Endocrine Therapy - 2 year(s) ago
Nearly all patients with HR-positive breast cancer are treated with endocrine therapy, yet Black women are 4 times more likely to die of this disease compared with White women.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Nearly all patients with HR-positive breast cancer are treated with endocrine therapy, yet Black women are 4 times more likely to die of this disease compared with White women. #bcsm #AACR22 | @AACR @cityofhope https://t.co/rqGRivLHCE
-
-
Mashup Score: 0Black vs White Women With Breast Cancer Experience Varying Results With Neoadjuvant Endocrine Therapy - 2 year(s) ago
Nearly all patients with HR-positive breast cancer are treated with endocrine therapy, yet Black women are 4 times more likely to die of this disease compared with White women.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Nearly all patients with HR-positive breast cancer are treated with endocrine therapy, yet Black women are 4 times more likely to die of this disease compared with White women. #bcsm #AACR22 | @AACR @VeronicaJonesMD https://t.co/wUGyhYWWc2
-
-
Mashup Score: 0
Abstract. Scientific advances in the late 19th century set the stage for progress in understanding and treating cancer, a disease that was previously considered almost hopeless. One hundred years later, cancer prevention is becoming an increasingly important focus for oncology research. New tools and ideas bring to the field some extremely promising molecular, organizational, social, and…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ICYMI – #CancerPrevention Prioritized at @AACR Annual Meeting and a New Working Group: Commentary by @adrianaalbini1. https://t.co/4d6aA5XNfV #AACR22 https://t.co/mJr0rNZRMl
-
-
Mashup Score: 0
Abstract. Scientific advances in the late 19th century set the stage for progress in understanding and treating cancer, a disease that was previously considered almost hopeless. One hundred years later, cancer prevention is becoming an increasingly important focus for oncology research. New tools and ideas bring to the field some extremely promising molecular, organizational, social, and…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ICYMI – #CancerPrevention Prioritized at @AACR Annual Meeting and a New Working Group: Commentary by @adrianaalbini1. https://t.co/5ChvRX0gav #AACR22 https://t.co/0gqKo49YgI
-
-
Mashup Score: 0
Abstract. Scientific advances in the late 19th century set the stage for progress in understanding and treating cancer, a disease that was previously considered almost hopeless. One hundred years later, cancer prevention is becoming an increasingly important focus for oncology research. New tools and ideas bring to the field some extremely promising molecular, organizational, social, and…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#CancerPrevention Prioritized at @AACR Annual Meeting and a New Working Group: Commentary by @adrianaalbini1. https://t.co/MaJMkuQUzf #AACR22 https://t.co/IZXOweOnQA
-
If you want more regarding the #AACR22 session on Disparities and Cancer Outcomes, check out this new paper on on neighborhood SES and racial and ethnic survival #disparities in oral cavity and laryngeal cancer by @angela_mazul and colleagues. https://t.co/OiUX7PsyNe @WUSTLmed https://t.co/ZebxELTAxF